20th September 2011

KARPAS 241 Human Monoblastic cell line

Code: CL20

KARPAS 241 Human Monoblastic cell line useful in oncology research, developed at the University of Cambridge.

Publications:

Immunopharmacology 1982, 5(2) 123–7

Brit J Haematology 1980, 44, 415–424

Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. We have partnered with ECACC (The European Collection of Cell Cultures; a Public Health England Culture Collection) to manage distribution of the majority of these cells on our behalf. Enquires to either organisation are welcomed.

Make an Enquiryread more arrow

Enquiry for KARPAS 241 Human Monoblastic cell line

Reagents Enquiry

To find out more about how this website collects your personal data see www.enterprise.cam.ac.uk/about-us/information-compliance/data-protection/core-privacy-notices/website-users-use-personal-information/

  • In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. A backup of your data will be held but only authorised individuals will be able to access your data. If you would like your data to be removed, please email support@thewebkitchen.co.uk.

Share

Categories

Cell lines
Monoclonal hybridomas
Other
Plasmids
Polyclonal antibodies
Recombinant proteins
Single-chain variable fragment
Small molecules

Related News

View Article
Top US, UK, and EU universities work together to help economies fuel post-COVID recovery 18th September, 2020
View Article
Cambridge spin-out Sorex Sensors completes £900k funding round 25th August, 2020
View Article
Cambridge spin-out doses first subject with treatment for alpha-1-antitrypsin deficiency 19th August, 2020
View Article
Cambridge Enterprise leads strategic funding round for Bond180 20th July, 2020